COLUBRISMX
ColubrisMX is developing a minimally invasive microsurgical robotic device that can treat life-threatening conditions such as fetal malformations and brain abnormalities through microsurgery. These state-of-the-art, minimally invasive, microsurgical robots will perform procedures in delicate regions of the body that cannot be accessed by current technology.
COLUBRISMX
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2017-03-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.colubrismx.com
Total Employee:
11+
Status:
Active
Contact:
281-846-6597
Email Addresses:
[email protected]
Total Funding:
86.74 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Office 365 Mail JsDelivr
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Bicara Therapeutics
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Praxis Precision Medicines
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Current Employees Featured
Founder
Investors List
Crescent Enterprises Venture Capital
Crescent Enterprises Venture Capital investment in Series A - ColubrisMX
Official Site Inspections
http://www.colubrismx.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "ColubrisMX"
ColubrisMX Company Profile - Office Locations, Competitors
ColubrisMX has 1 employees at their 1 location and $90.74 m in total funding,. See insights on ColubrisMX including office locations, competitors, revenue, financials, executives, …See details»
ColubrisMX, Inc. Announces Corporate Rebranding to …
HOUSTON, June 30, 2022 /PRNewswire/ -- ColubrisMX, Inc., developer of the world's first flexible endoluminal robotic system which enables scar-free and less invasive surgical procedures, ...See details»
ColubrisMX Information - RocketReach
ColubrisMX is a Houston-based micro-robotic medical device enterprise. XCath is developing steerable robotic microcatheters which will be used in treating cerebral strokes and other …See details»
ColubrisMX, Inc. Announces Corporate Rebranding to …
%PDF-1.7 %âãÏÓ 48 0 obj > endobj 68 0 obj >/Filter/FlateDecode/ID[]/Index[48 64]/Info 47 0 R/Length 102/Prev 206553/Root 49 0 R/Size 112/Type/XRef/W[1 3 1 ...See details»
ColubrisMX - Funding, Financials, Valuation & Investors
ColubrisMX is developing a minimally invasive miscrosurgical robotic device. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. ... How much …See details»
ColubrisMX, Inc. Announces Corporate Rebranding To …
Jul 1, 2022 ColubrisMX, Inc., developer of the world’s first flexible endoluminal robotic system which enables scar-free and less invasive surgical procedures, today announced that the …See details»
ColubrisMX, Inc. rebrands to ENDOQUEST Robotics™
Jul 1, 2022 New brand identity highlights company leadership in advancing innovative “scar-free” technology for endoluminal robotic surgeries.. ColubrisMX, Inc., developer of the world’s first flexible endoluminal robotic system which …See details»
ColubrisMX - Biotechnology - Overview, Competitors, and …
ColubrisMX is developing a minimally invasive microsurgical robotic device that can treat life-threatening conditions such as fetal malformations and brain abnormalities through …See details»
ColubrisMX - Updates, News, Events, Signals & Triggers
ColubrisMX is developing a minimally invasive miscrosurgical robotic device.See details»
ColubrisMX, Inc. Announces Corporate Rebranding to …
Jun 30, 2022 New brand identity highlights company leadership in advancing innovative "scar-free" technology for endoluminal robotic surgeries. HOUSTON, June 30, 2022 /PRNewswire/ - …See details»
ColubrisMX, Inc. Announces Corporate Rebranding to …
Jun 30, 2022 New brand identity highlights company leadership in advancing innovative "scar-free" technology for endoluminal robotic surgeries. HOUSTON, June 30, 2022 /PRNewswire/ - …See details»
ColubrisMX Announces Corporate Rebranding to ENDOQUEST …
Jul 1, 2022 ColubrisMX, Inc., developer of the world’s first flexible endoluminal robotic system which enables scar-free and less invasive surgical procedures, announced that the Company …See details»
ColubrisMX Stock Data, Filings, Earnings, News & Transcripts
Get the latest news, data and filings for ColubrisMX, with free alerts. Includes transcripts, social sentiment, and more.See details»
ColubrisMX - Contacts, Employees, Board Members, Advisors
ColubrisMX has 3 current employee profiles, including Consultant Chief Financial Officer Christine Antalik. Christine Antalik Consultant Chief Financial Officer Kurt Azarbarzin Chief Executive …See details»
ColubrisMX Announces Participation in Presentations at Society of ...
Jun 28, 2022 Details on ColubrisMX presentations: Title: Emerging Robotic Platforms Date and Time: Thursday, June 30, 2022, 3:15-3:45 PM ET Participants: Kurt Azarbarzin, CEO, …See details»
ColubrisMX Announces Participation in Presentations at Society of ...
Jun 28, 2022 ColubrisMX has developed the Endoluminal Surgical (ELS) System, the world's first endoluminal robotic surgical system that makes it possible for therapeutic endoscopists …See details»
ColubrisMX - Tech Stack, Apps, Patents & Trademarks - Crunchbase
The intellectual property of ColubrisMX includes 2 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, ColubrisMX has …See details»
ColubrisMX on Show at Society of Robotic and Digital Surgery …
ColubrisMX, developer of the world’s first flexible endoluminal robotic system which enables scar-free and less invasive surgical procedures, announced that company CEO Kurt Azarbarzin will …See details»
Series B - ColubrisMX - 2021-05-03 - Crunchbase
May 3, 2021 ColubrisMX raised $76076973 on 2021-05-03 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log …See details»